Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

1 Oct 2021 14:15

RNS Number : 7847N
Synectics PLC
01 October 2021
 

 

 

RNS

 

1 October 2021

 

 

 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR dealings

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that earlier today, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 14,843 ordinary shares of 20 pence each in the Company at a price of £1.05 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2021.

 

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was £1.35.

 

As a result of this purchase, the Company has been notified that the following Executive Directors and PDMRs have acquired the following interests in shares of the Company:

 

Name

Position

Status

Number of Shares purchased by the Trustee

Paul Webb

Chief Executive

Executive Director

857

David Bedford

Finance Director

Executive Director

857

Greg Alcorn

Divisional Director

PDMR

857

David Lowe

Divisional Director

PDMR

857

 

In addition, David Bedford, Finance Director of the Company has notified the Company that he too purchased 5,000 ordinary shares of 20p each in the Company at £1.05 per share earlier today.

 

Following these purchases, the interests of Messrs Webb, Bedford, Alcorn and Lowe in the shares of the Company are as follows:

 

Name

Shares Held

Interest in Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

57,115

536,327

593,442

3.33%

David Bedford

20,000

186,857

206,857

1.16%

Greg Alcorn

-

25,655

25,655

0.14%

David Lowe

15,000

43,177

58,177

0.33%

 

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Claire Stewart, Company Secretary

email: legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten / Henry Willcocks

 

 

 Ends

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADEFEFLFFFA
Date   Source Headline
3rd Jan 20065:28 pmRNSIssue of Equity
20th Dec 20054:32 pmRNSHolding(s) in Company
20th Dec 200512:53 pmRNSDirector/PDMR Shareholding
20th Dec 200512:41 pmRNSDirector/PDMR Shareholding
19th Dec 20053:22 pmRNSDirector/PDMR Shareholding
19th Dec 20052:13 pmRNSTransaction in Own Shares
16th Dec 20053:30 pmRNSIssue of Equity
13th Dec 20055:16 pmRNSIssue of Equity
8th Dec 200510:55 amRNSNotice of Results
8th Dec 20058:23 amRNSStrategic Alliance
5th Dec 20053:02 pmRNSHolding in Company
5th Dec 20052:59 pmRNSShare Allotment
18th Nov 20054:26 pmRNSRecommended Offer for Protec
18th Nov 20057:00 amRNSRe Recommended offer
11th Nov 20052:17 pmRNSHolding(s) in Company
10th Nov 20052:53 pmRNSHolding(s) in Company
9th Nov 20055:03 pmRNSRecommended Offer for Protec
9th Nov 20053:16 pmRNSHolding(s) in Company
7th Nov 20057:00 amRNS First Dealings
4th Nov 20053:46 pmRNSOffer Extended
21st Oct 20055:14 pmRNSOffer Update
21st Oct 20052:10 pmRNSRule 8.3- Quadnetics Group
19th Oct 20052:45 pmRNSOffer Update
19th Oct 200512:11 pmRNSRule 8.3-Quadnetics Group PLC
19th Oct 200510:44 amRNSRule 8.3- Quadnetics Group
17th Oct 200512:15 pmRNSResult of EGM
14th Oct 20051:13 pmRNSRule 8.3- Quadnetics Group
12th Oct 200512:06 pmRNSRule 8.3- Quadnetics PLC
10th Oct 20055:38 pmRNSRule 8.3-Quadnetics Grp-Amend
10th Oct 200511:22 amRNSRule 8.3- Quadnetics Group
6th Oct 20053:48 pmRNSHolding in Company
5th Oct 200512:03 pmRNSRule 8.3-Quadnetics-Amendment
5th Oct 200511:27 amRNSRule 8.3-Quadnetics Group PLC
4th Oct 20059:32 amRNSRule 8.3-Quadnetics Group PLC
30th Sep 20056:06 pmRNSRecommended Offer
29th Sep 200511:55 amRNSRule 8.3- Quadnetics
23rd Sep 20057:01 amRNSRecommended Offer for Protec
15th Sep 20057:04 amRNSFinal Results
8th Sep 20054:10 pmRNSNotice of Results
5th Aug 200511:18 amRNSDirectorate Change
24th Jun 20058:54 amRNSAllotment of shares
21st Jun 200511:22 amRNSAllotment of Shares
23rd May 20054:19 pmRNSHolding in Company
17th May 20054:28 pmRNSDirector Shareholding
16th May 200511:42 amRNSIssue of Shares
4th May 20059:00 amRNSHoldings in Company
3rd May 20052:42 pmRNSDirector Shareholding
22nd Apr 200512:55 pmRNSAcquisition
11th Feb 20054:55 pmRNSHolding in Company
7th Feb 20052:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.